Understanding Medulloblastoma Subtypes and Their Origins
Author Information
Author(s): Gibson P, Tong Y, Robinson G, Thompson MC, Currle DS, Eden C, Kranenburg TA, Hogg T, Poppleton H, Martin J, Finkelstein D, Pounds S, Weiss A, Patay Z, Scoggins M, Ogg R, Pei Y, Yang ZJ, Brun S, Lee Y, Zindy F, Lindsey JC, Taketo MM, Boop FA, Sanford RA, Gajjar A, Clifford SC, Roussel MF, McKinnon PJ, Gutmann DH, Ellison DW, Wechsler-Reya R, Gilbertson RJ
Hypothesis
Medulloblastoma subtypes have distinct developmental origins that influence their behavior and treatment.
Conclusion
Recognizing the distinct molecular origins of medulloblastoma subtypes may significantly impact diagnosis, prognosis, and therapy.
Supporting Evidence
- Medulloblastomas can be separated into subtypes based on altered molecular pathways.
- SHH-subtype tumors tend to present earlier and have worse prognoses.
- WNT-subtype tumors arise in the dorsal brainstem and have better prognoses.
- CTNNB1 mutations are associated with WNT-subtype medulloblastomas.
- Concurrent loss of CTNNB1 and p53 leads to medulloblastoma development in mice.
Takeaway
Medulloblastomas are different types of brain tumors in kids, and knowing where they come from can help doctors treat them better.
Methodology
The authors used databases to analyze gene expression and created a mouse model to study the origins of medulloblastoma subtypes.
Want to read the original?
Access the complete publication on the publisher's website